Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Violet oil versus diphenhydramine for nocturnal cough in children with common cold
IRCT20191127045522N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of diphenhydramine in upper respiratory infection (URI) and nasopharyngitis (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Cough frequency, Cough severity and 2 more. Started Apr 2020; status: completed.
02
Drugs
diphenhydramine
03
Conditions
upper respiratory infection (URI)nasopharyngitis
Beyond the preview
Go deeper on IRCT20191127045522N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191127045522N1.